Affymax stock reaction misplaced, says RW Baird Baird believes yesterday's reaction in shares of Affymax (AFFY) was misplaced in respect to the Fresenius (FMS) pilot program. The firm sees yesterday's communication as standard operating procedure and is actually a strong positive signal suggesting the chances of an expanded contract are now materially higher. Shares are Outperform rated with a $30 price target.
News For AFFY;FMS From The Last 14 Days
Check below for free stories on AFFY;FMS the last two weeks.